Dr Colin A. Morton is a speaker at the SCFSA online Skin Cancer Update

Topic: Photodynamic Therapy in the UK – current trends

MB ChB, MD, FRCP(UK)

Abstract:
Photodynamic Therapy in the UK – current trends

Topical PDT is widely practiced for its licensed indications in the UK, reflecting the
recommendations of evidence-based guidelines (Br J Dermatol 2019;180:730-739).

Daylight PDT is increasingly used during warmer months for actinic keratoses in the UK, but treatment predominantly remains with conventional PDT during the winter and for Bowen’s Disease and superficial BCC.

Although approved for nodular BCC, topical PDT is more commonly used as a second-line option for surgery.

There is emerging literature on enhancing PDT protocols or combined PDT with another treatment to increase response rates.

NICE-accredited Service Standards ensure the safe practice of PDT by appropriately trained healthcare professionals (http://www.bad.org.uk).

Present

NHS Forth Valley, Stirling, UK

Consultant Dermatologist and Clinical Lead

1996-1998

University of Glasgow

Doctor of Medicine MD

1981-1986

University of Glasgow

Bachelor of Medicine, Bachelor of Surgery
MBChB

Dr Colin A. Morton History and accolades

Dr Colin A. Morton, MB ChB, MD, FRCP(UK), Consultant Dermatologist and Clinical Lead, NHS Forth Valley, Stirling, UK

Honorary Clinical Associate Professor, Department of Dermatology, University of Glasgow.

He is a national Dermatology advisor to the Chief Medical Officer (Scotland), a past president of the Scottish Dermatology Society, and a current member of the British Association of Dermatologists’ Clinical Services Committee.

Dr Morton is the Operational Clinical Lead for the AI Skin Cancer Consortium, led by NHS Scotland, and supported by the Chief Scientists Office (Scotland) seeking to implement AI into the routine pathway of care for NHS patients.

He is also the lead clinician for DDA rollout, a digital dermatology consultation platform being rolled out across NHS Scotland.

His MD thesis was in Photodynamic Therapy for skin cancer.

Dr Morton has authored multiple scientific publications and several book chapters.

He is co-author of U.K., European and International guidelines for best practices in skin cancer.